Study Director in vitro Endocrine Disruption / in-vitro Toxicology

Study Director in vitro Endocrine Disruption / in-vitro Toxicology Req ID #:  105932 Location: 

S-Hertogenbosch, NL, 5231 DD For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about. Functie The department Discovery & Environmental Sciences has a high focus on the performance of in vitro alternatives for in vivo studies and is specialized in in vitro endocrine disruptor studies. To support our in vitro endocrine disruptor studies we make use of various cell cultures and analytical techniques to measure responses. Because the field of Endocrine Disruption is a rapidly expanding and changing discipline with growing importance, flexibility, enthusiasm, quality awareness and technical expertise are necessary. Anticipating future growth, we are looking for a

Study Director In vitro Endocrine Disurption / in-vitro Toxicology

About the opportunity:

• As a Study Director (SD), you are responsible for the conduct of in-vitro Endocrine Disruption studies in the Discovery & Environmental Sciences department.

• Under the Study Director's command in-vitro studies are designed, executed and reported. The SD takes care of and has the responsibility for the progress and the quality of the studies, the scientific content and the interpretation/reporting of the study results. The SD also stays in close contact with the clients and all other parties involved in the execution of the studies.

• Besides running studies yourself, you will be involved in meetings with clients, representing the company at scientific meetings or on industry working parties, liaising with fellow Study Directors and other Charles River colleagues.

About you:

• You will have a MSc. or Ph.D. degree in a relevant field, e.g. in-vitro Toxicology, Biology, Endocrine Disruption or equivalent.

• You have experience with working in a laboratory setting (cell culture, ELISA and/or LC-MS), trouble shooting and assay development.

• A qualification in toxicology is highly desirable. Professional memberships, certification and qualification in relevant topics in toxicology will count in your favor.

• Understanding of Good Laboratory Principles (GLP) and certification to work with radioactive materials is a plus.

• You have excellent communication and reporting skills, both in Dutch and English.

• You have a pro-active, results-oriented, enthusiastic, dynamic and flexible attitude.

About Safety Assessment

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 14,000 employees within 80 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2018, revenue increased by 22% to $2.27 billion from $1.86 billion in 2017.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2018.

Equal Employment Opportunity 

Charles River Laboratories is an Equal Opportunity Employer - M/F/Disabled/Vet

.

Job Segment: Toxicology, Biotech, Manager, Laboratory, Pharmaceutical, Science, Management